Literature DB >> 23322030

Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects.

Bing-Hu Li1, Li-Li Zhang, Yan-Wei Yin, Yan Pi, Lu Guo, Qing-Wu Yang, Chang-Yue Gao, Chuan-Qin Fang, Jing-Zhou Wang, Jing Xiang, Jing-Cheng Li.   

Abstract

Epidemiological studies have evaluated the association between interleukin-1 (IL-1)α C(-889)T polymorphism and Alzheimer's disease (AD), but the results remain inconclusive. This meta-analysis was, therefore, designed to clarify these controversies. Systematic searches of electronic databases Embase, PubMed, and Web of Science as well as hand searching of the references of identified articles and the meeting abstracts were performed. Statistical analyses were performed using software Review Manager (Version 5.1.2) and Stata (Version 11.0). The pooled odds ratios (ORs) with 95 % confidence intervals (95 % CIs) were calculated. A total of 28 publications including 29 studies were involved. There was a significant association between IL-1α C(-889)T polymorphism and AD (for T allele vs. C allele: OR = 1.14, 95 % CI = 1.07-1.21; for T/T vs. C/C: OR = 1.39, 95 % CI = 1.18-1.63; for dominant model: OR = 1.13, 95 % CI = 1.04-1.22; and for recessive model: OR = 1.39, 95 % CI = 1.20-1.60). Significant association was found for Asians, Caucasians, and early-onset Alzheimer's disease (EOAD) but for late-onset Alzheimer's disease (LOAD). This meta-analysis indicates that there is a significant association between IL-1α C(-889)T polymorphism and AD as well as EOAD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23322030     DOI: 10.1007/s00702-012-0867-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  52 in total

Review 1.  Cytokines and cognition--the case for a head-to-toe inflammatory paradigm.

Authors:  Craig J Wilson; Caleb E Finch; Harvey J Cohen
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

2.  Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo.

Authors:  J G Sheng; S G Zhu; R A Jones; W S Griffin; R E Mrak
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients.

Authors:  K M Mattila; J O Rinne; T Lehtimäki; M Röyttä; J P Ahonen; M Hurme
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

5.  Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J Stewart; P McCarron; S Love; H V Vinters; J W Ironside; D M A Mann; D I Graham; J A R Nicoll
Journal:  Stroke       Date:  2003-08-28       Impact factor: 7.914

6.  Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.

Authors:  Onofre Combarros; Marisa Sánchez-Guerra; Jon Infante; Javier Llorca; José Berciano
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

7.  Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population.

Authors:  X-Q Li; J-W Zhang; Z-X Zhang; D Chen; Q-M Qu
Journal:  J Neural Transm (Vienna)       Date:  2004-05-12       Impact factor: 3.575

8.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

9.  Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease.

Authors:  F L Sciacca; C Ferri; F Licastro; F Veglia; I Biunno; A Gavazzi; E Calabrese; F Martinelli Boneschi; S Sorbi; C Mariani; M Franceschi; L M E Grimaldi
Journal:  Neurobiol Aging       Date:  2003-11       Impact factor: 4.673

10.  Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia.

Authors:  Yu-Min Kuo; Pao-Chi Liao; Chingju Lin; Chih-Wei Wu; Hsueh-Meei Huang; Chih-Chien Lin; Liang-Jen Chuo
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

View more
  6 in total

Review 1.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

2.  Genetic variants and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Axel Martin; Erica Braun; Maria Kryza-Lacombe; Kenneth Cheung; Ajay Sharma; Sofia Dimitriadoy; Kelli O'Connell; Siok Leong; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

3.  Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population.

Authors:  Sanish Sathyan; Nir Barzilai; Gil Atzmon; Sofiya Milman; Emmeline Ayers; Joe Verghese
Journal:  Neurobiol Aging       Date:  2017-06-19       Impact factor: 4.673

4.  Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Authors:  Xiaoliu Dong; Li Zhang; Qingling Meng; Qiuyan Gao
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

5.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

6.  Genetic Insights Into Frailty: Association of 9p21-23 Locus With Frailty.

Authors:  Sanish Sathyan; Nir Barzilai; Gil Atzmon; Sofiya Milman; Emmeline Ayers; Joe Verghese
Journal:  Front Med (Lausanne)       Date:  2018-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.